AzTrials
AzTrials

Deglutition DisordersICU-SwallowNCT04428749

Swallowing Difficulties in ICU Patients [Synkebesvær Hos Intensivpatienter]

An observational study of Deglutition Disorders and Critical Illness, run by Hospitalsenheden Vest at 1 site in Denmark.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Swallow disorders or dysphagia related to mechanical ventilation affects between 1,300 and 2,000 patients in Danish intensive care units every year and increases aspiration, pneumonia and risk of dying. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Deglutition Disorders, Critical Illness
What is being tested?
Yale Swallow Protocol and FEES (fiberoptic endoscopic evaluation of swallowing)
Type of treatment
Pill or oral medicine
How many people
35 participants
Where
1 siteDenmark
Study dates
1 Apr 2020to 1 Jun 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Critically ill adult patients from all clinical specialties who have been extubated after mechanical ventilation.

Who may be able to join

  • > 18 years
  • No prior records of dysphagia
  • Extubated after mechanical ventilation > 24 hours.
  • Awake and alert with no sign of ICU delirium.
  • Must understand Danish, as all information available about the study is in Danish.

Who cannot join

  • Patients who are unable to undergo the YSP
  • Patients who are unable to undergo the FEES

Trial locations and contacts

1 site in 1 country.

Denmark1 site
  • Regionshospitalet Holstebro

    Holstebro, Central Jutland, 7500

Other trials in Denmark

About this study

Swallow disorders or dysphagia related to mechanical ventilation affects between 1,300 and 2,000 patients in Danish intensive care units every year and increases aspiration, pneumonia and risk of dying. In intensive care units, dysphagia may vary around the clock as fatigue and fluctuating alertness play an important role for the patients' ability to swallow effectively without aspiration to the airway. For this reason, ICU nurses must be able to assess dysphagia in the ICU patient day and night, but guidelines are lacking.

One of the simplest and most sensitive methods is the Yale Swallow Protocol, however, this protocol requires translation and validation before it can be implemented in Danish intensive care units. This project aims to translate and validate the Yale Swallow Protocol for use in Danish intensive care units. Furthermore, this project will explore nurses' perceptions and management of dysphagia in the intensive care unit as well as feasibility and acceptability of the Yale Swallow Protocol.

Read the detailed description

Introduction Dysphagia caused by intubation and mechanical ventilation affects between 1.300 - 2.000 patients in Danish intensive care units (ICU's) every year. Dysphagia increases the risk of aspiration, pneumonia, repeated mechanical ventilation and mortality. Despite this, national and international guidelines for treating dysphagia in the ICU are lacking. In ICU patients, dysphagia may vary around the clock as fatigue and cerebral status plays an important role for the patients' ability to swallow effectively without aspiration. For this reason, ICU nurses must be able to assess dysphagia in the ICU patient day and night. This will be an important addition to assessments made by occupational therapists usually only available in the morning hours. However, for nurses to be able to assess dysphagia in the ICU patients; development and validation of screening procedures are highly needed.

The development of a validated screening procedure to detect dysphagia in ICU patients will furthermore pave the way for the developing and testing nursing interventions aiming at improving dysphagia in ICU patients. This may reduce complications and improve quality of life in patients.

Dysphagia related to mechanical ventilation and intensive care The swallow function depends on a complicated interplay between more than 30 muscle pairs, cranial nerves and areas in the cortex and the medulla oblongata. Causes for dysphagia in ICU patients are only partially understood, however, the following factors have been suggested as significant: 1) Trauma to the pharynx caused by intubation (placing a tube for mechanical ventilation in the airway), 2) Neuromyopathy resulting in muscular weakness, 3) Decreased level of consciousness caused by medication, delirium or critical illness. Moreover, these factors may cause dysphagia in ICU patients to vary from day to night.

Dysphagia is a serious complication to critical illness, potentially increasing mortality. Despite this, research shows that nursing practice varies greatly. Nurses have different views on what constitutes safe swallowing. Nonetheless, it often falls upon nurses to assess patients swallowing function and determine whether to offer the patient something to eat and drink or not. Thus, developing valid screening methods that can be used by ICU nurses may improve patient safety and reduce complications due to dysphagia caused by intubation, mechanical ventilation and critical illness.

Diagnosing dysphagia using FEES Dysphagia can be diagnosed using instrumental methods such as the fiberoptic endoscopic evaluation of swallowing (FEES). This method is considered a gold standard in assessing dysphagia. FEES may be performed bed-side by physicians or occupational therapists by testing different foods and consistencies, but some patients find the FEES disagreeable. A clinical examination by occupational therapists is another way to diagnose dysphagia, however, silent aspiration without choking or coughing is difficult to detect in a clinical examination.

(NOTE: In Denmark, the speech language therapist is usually an occupational therapist).

Screening for dysphagia Screening for dysphagia in general hospital populations is possible by using different screening methods.

One of the most rigorously validated tests is the Yale Swallow Protocol (YSP). The YSP is a three-step method consisting of an assessment of the patient's awareness, the patient's ability to follow simple instructions and finally the patient's ability to drink 90 ml water from a cup or by straw without stopping, choking or coughing. The YSP has high sensitivity of 0.96, thus effectively identifying patients who may safely begin oral feeding and drinking. The specificity 0.5 indicates that patients who fail the YSP will need a specialized assessment before eating and drinking is commenced. The clinical importance of this is that nurses may employ the YSP at all hours to identify patients at risk, and thereby be able to prevent aspiration detrimental to patient recovery. Moreover, patients not at risk can begin oral feeding earlier, which may improve nutritional status and wellbeing in the patient. However, dysphagia in ICU patients varies from other hospital patients because of intubation, muscle weakness and alternating level of consciousness. Therefore it is necessary to validate a translated version of the YSP on ICU patients to determine its predictive abilities. In addition, skilled clinicians' uptake of a new screening method is a complex process. Therefore, the feasibility and acceptability of the YSP in a Danish ICU needs to be explored before the YSP can be recommended for implementation on a greater scale.

Research questions

  1. Is systematic screening of dysphagia in ICU patients using the Yale Swallow protocol feasible and acceptable to clinicians and patients?
  2. Can the Yale Swallow Protocol, administered by ICU nurses bed side 24 hours a day, identify dysphagia in ICU patients? What are the predictive abilities compared to FEES (gold standard)?

Methods

STUDY 1

Design: Feasibility study. The aim of this study is to explore feasibility of implementing and evaluating the YSP in a regional ICU and acceptability among clinicians and patients. This includes exploring barriers and facilitators to screening ICU patients for dysphagia, fidelity to the YSP and FEES methods and fidelity to recommendations for oral intake of food and drinks based on the YSP and FEES.

The four-phased feasibility study will address feasibility of both the YSP and research methods for study 2.

STUDY 2

Design: Prospective observational study, which will be adjusted based on the feasibility study (study 1).

Intervention:

  1. Screening 2-4 hours after extubation:

Ability to swallow is assessed by an ICU nurse using the YSP. If the YSP is negative, the patient may start oral feeding and drinking. In case of a positive YSP, the screening may be repeated within the next 24 hours provided the patient improves clinically. If YSP continues to be positive the patient is referred to assessment by a speech language pathologist (SLP).

  1. Screening within 24 hours:

To evaluate YSP against the FEES, the patient undergoes 1) YSP performed by an ICU nurse followed by 2) FEES performed by an occupational therapist (until PAS>6 (aspiration on any food consistency on the Penetration Aspiration Scale). The occupational therapist will be blinded to the assessment made by the ICU nurses. Patients will follow recommendations for oral feeding and drinking as given by the occupational therapist.

Data:

For patients, the following data will be recorded: time and results of the initial YSP screening 2-4 hours post extubation, recommendation for oral feeding and drinking, time and results of the YSP and the FEES performed within 24 hours of extubation and recommendation for oral feeding and drinking. In addition, sex, age, diagnosis, Simplified Acute Physiology Score (SAPSIII) , Charlson Comorbidity Index, chronic obstructive pulmonary disease, length of stay in hospital, length of stay in ICU, time on mechanical ventilation, new pneumonia following extubation, FOIS (Functional Oral Intake Scale) and death within 30 days.

For clinicians performing the YSP and FEES, the following data will be recorded: age, sex, profession, experience in years, and ICU experience in years.

Sample size: Given a prevalence of dysphagia among acute ICU patients of 18 %; a sensitivity of YSP of 0.96 and a specificity of 0.5, then inclusion of 25 patients will be able to show a negative likelihood ratio (LR-) of 0.1 [95 % CI 0,00; 5,74], which means that almost all patients passing the YSP will be without dysphagia. Estimating the attrition rate to be 25 %, 35 patients will be included in the study.

Analysis: Screening by YSP and assessment by FEES with 24 hours will be tabulated in a 2x2 table, calculating the sensitivity, specificity, positive predictive value and negative predictive value of YSP compared to FEES. Correlations between patient characteristics will be calculated using Pearson and Spearman correlation statistics as appropriate.

Research ethics

All participants receive written and oral information about the purpose of the study and give signed, informed consent. Relatives of patients are informed about the study. In case a participant is affected adversely by participation, support will be offered by nurses and physicians from the ICU.

The study is approved by the Health Research Committee of Region Central Jutland. The study is registered with Danish Data protection Agency and data will be stored in REDCap hosted by Aarhus University and Midt-X, a research data site hosted by the Central Denmark Region.

All data will be anonymized before shared or published; all data will be published.

Perspectives

If screening with the YSP can identify dysphagia in the critically ill patients, this will allow oral feeding and drinking in many patients, leading to improved nutritional status and increased patient satisfaction with no compromise of patient safety. Moreover, an effective screening method for dysphagia may pave the way for developing nursing interventions to prevent dysphagia from developing in the intensive care patient. In turn, this may reduce complications, human suffering and costs.

Being tested
Yale Swallow Protocol, FEES (fiberoptic endoscopic evaluation of swallowing)
Medical subject headings
Deglutition Disorders, Critical Illness

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Yale Swallow ProtocolDiagnostic test

    The YSP is a three-step method consisting of an assessment of the patient's awareness, the patient's ability to follow simple instructions and finally the patient's ability to drink 90 ml water from a cup or by straw without stopping, choking or coughing.

  • FEES (fiberoptic endoscopic evaluation of swallowing)Diagnostic test

    The FEES will be performed bedside by an experienced occupational therapists. The patient will be sitting upright in a chair and be given 1) 2 spoons of applesauce, 2) 2 spoons of water, 3) several sips of water, 4) 90 ml of water. All items colored blue.

    The FEES will use a single-use AMBU rhino-laryngo scope slim and the AMBU monitor. the examination will be terminated in case of aspiration below the vocal cords.

Study groups in NCT04428749
Study groupRoleWhat they receive
Study group1. Participants are screened using the Yale Swallow Protocol (YSP) 2-4 hours after extubation: Ability to swallow is assessed by an ICU nurse using the YSP. If the YSP is negative, the patient may start oral feeding and drinking. In case of a positive YSP, the screening may be repeated within the next 24 hours provided the patient improves clinically. If YSP continues to be positive the patient is referred to assessment by a speech language pathologist (SLP). 2. Participants are screened within 24 hours: To evaluate YSP against the FEES, the patient undergoes 1) YSP performed by an ICU nurse followed by 2) FEES performed by a SLP (until PAS>6 (aspiration on any food consistency on the Penetration Aspiration Scale (20)). The SLP will be blinded to the assessment made by the ICU nurses. Patients will follow recommendations for oral feeding and drinking as given by the SLP.
Receives: Diagnostic Test: Yale Swallow Protocol; Diagnostic Test: FEES (fiberoptic endoscopic evaluation of swallowing)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Aspiration on FEES

    Penetration aspiration scale (PAS scale) equal to or larger than 6

    Measured: Within 24 hours of extubation

  2. Yale Swallow protocol

    Passed or not passed

    Measured: Within 30 minutes of the FEES

Secondary outcomes (1)
  1. Mortality

    Dead or alive according to patient record

    Measured: 30 days after extubation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jun 2020
  2. Study start1 Apr 2020
  3. Primary completion12 Dec 2022 (estimated)
  4. Study completion1 Jun 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
35 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04428749
Sponsor's protocol ID
69184
Acronym
ICU-Swallow
Status last verified
Nov 2021
First submitted
10 Jun 2020
Last updated
16 Nov 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Deglutition Disorders and Critical Illness, run by Hospitalsenheden Vest at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 16 Nov 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Aspiration on FEES (time frame: Within 24 hours of extubation). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Nov 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in